Satellos expects to begin first-in-human clinical trials mid-year for SAT-3247, an oral small molecule drug candidate in development as a novel regenerative medicine approach to treating DMD
.
Baystreet ca - Satellos Bioscience Inc baystreet.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baystreet.ca Daily Mail and Mail on Sunday newspapers.
Satellos Bioscience Inc. announced the formation of a Clinical Advisory Board comprised of distinguished clinical research leaders and experts in drug development in genetic muscle disorders,.
Satellos Bioscience Inc Opens the Market marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Satellos Bioscience Announces Q1 2024 Financial Results and Operational Highlights financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.